Jim and Mike et al,
Ali Moghtaderi and I have been working on adjusting incidence/prevalence data for vaccine preventable diseases by different levels of disease and time aggregation.
We are in the process of extending our previous NBER working paper on childhood vaccines to incorporate diseases outbreaks.
So this about epidemics (US data only) rather than pandemics, but hope it helps.
Avi
--
Avi Dor, PhD
Professor
Director, Health Economics Program
Department of Health Policy and Management
Milken Institute School of Public Health
George Washington University
Washington DC 20052
Research Associate
National Bureau of Economic Research (NBER)
Sent from my iPhone
>> On Mar 17, 2020, at 7:30 PM, Grossman, Michael <MGrossman_at_gc.cuny.edu> wrote:
>
> Jim,
>
> In a previous message, you asked me whether anyone in the HE program have particular interest or expertise on pandemics. I’m pretty sure that Tomas Philipson does. He is a research associate in HC and HE but is on leave of absence as Chair of the Council of Economic Advisors. I am asking Tomas, HE program members, and Anup Malani, a research associate in DEV, to contact you if they have expertise or suggestions about people who you might want to contact.
>
> Best regards,
> Mike
>
>
>
> Michael Grossman
> National Bureau of Economic Research
> 5 Hanover Square, 16th Floor, Suite 1602
> New York, NY 10004-2630
> Tel: (646) 783-4407 (direct)
> Main: (646) 783-2656, ext. 107
> Fax: (917) 426-7015
> E-mail: mgrossman_at_gc.cuny.edu
> Home Page: http://mgrossman.ws.gc.cuny.edu/
Received on Thu Mar 19 2020 - 07:07:35 EDT
